Phenotype in patients with Gaucher disease and Parkinson disease

被引:31
作者
Ben Chetrit, Eli [1 ,2 ]
Alcalay, Roy N. [4 ]
Steiner-Birmanns, Bettina [2 ,3 ]
Altarescu, Gheona [1 ,2 ]
Phillips, Mici [1 ,2 ]
Elstein, Deborah [1 ,2 ]
Zimran, Ari [1 ,2 ]
机构
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Ein Kerem, Israel
[3] Shaare Zedek Med Ctr, Dept Neurol, IL-91031 Jerusalem, Israel
[4] Columbia Univ, Med Ctr, Dept Neurol, Nyc, NY USA
关键词
Gaucher disease; Parkinson disease; Glucocerebrosidase; Genotype; Ashkenazi Jewish; Enzyme replacement therapy; GLUCOCEREBROSIDASE MUTATIONS; RISK;
D O I
10.1016/j.bcmd.2012.11.011
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Previous reports have shown an increased risk for Parkinson disease (PD) among type 1 Gaucher disease (GD) patients. However, the number of the reported cases of GD/PD is small and it is unknown whether certain GD phenotypes are associated with an increased PD risk. Objective: To present GD and PD characteristics of adults affected by both diseases from a large Israeli GD and assess whether certain GD characteristics are associated with a higher risk for PD. Methods: Medical files of patients >18 years between 1990 and 2010 were reviewed for PD signs or symptoms. Available patients with PD underwent an additional neurological examination. Demographic and GD characteristics were compared between GD patients with and without PD using t-test and Fisher exact. Kaplan-Meier survival curves were used to estimate age-specific risk for PD among males and females. Age-specific risk for PD was compared between males and females using Cox Hazard ratio model. Results: 510 type 1 GD adults (233 males; 45.7%), were evaluated. 11 PD patients were identified (22%). Among those with GD/PD cognitive impairment was common (7/11). Two patients underwent successful deep brain stimulation (DBS). PD diagnosis was associated with male gender (81.8% versus 44.9% male, p=0.027) and older age (mean age, PD=62.8, non-PD=47.1, p=0.004). GD phenotype and severity did not differ between the two groups, including mean Zimran Severity Score index (7.7 versus 83), percent splenectomized (15.8% versus 27.3%), history of avascular necrosis (13.0% versus 27.3%) and percent ever treated with enzyme replacement (49.4% versus 45.5%). Conclusion: Male gender and older age are risk factors for PD among GD patients, but GD severity is not associated with increased risk for PD. Further research is required to assess which GD patients are at a higher risk for PD, and why. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:218 / 221
页数:4
相关论文
共 26 条
[1]
Alcalay RN, 2010, ARCH NEUROL-CHICAGO, V67, P1116, DOI 10.1001/archneurol.2010.194
[2]
Gaucher's disease with Parkinson's disease - Clinical and pathological aspects [J].
Bembi, B ;
Marsala, SZ ;
Sidransky, E ;
Ciana, G ;
Carrozzi, M ;
Zorzon, M ;
Martini, C ;
Gioulis, M ;
Pittis, MG ;
Capus, L .
NEUROLOGY, 2003, 61 (01) :99-101
[3]
The risk of Parkinson's disease in type 1 Gaucher disease [J].
Bultron, Gilberto ;
Kacena, Katherine ;
Pearson, Daniel ;
Boxer, Michael ;
Yang, Ruhua ;
Sathe, Swati ;
Pastores, Gregory ;
Mistry, Pramod K. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (02) :167-173
[4]
The MoCA Well-suited screen for cognitive impairment in Parkinson disease [J].
Dalrymple-Alford, J. C. ;
MacAskill, M. R. ;
Nakas, C. T. ;
Livingston, L. ;
Graham, C. ;
Crucian, G. P. ;
Melzer, T. R. ;
Kirwan, J. ;
Keenan, R. ;
Wells, S. ;
Porter, R. J. ;
Watts, R. ;
Anderson, T. J. .
NEUROLOGY, 2010, 75 (19) :1717-1725
[5]
Daniel S E, 1993, J Neural Transm Suppl, V39, P165
[6]
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 [J].
Dorsey, E. R. ;
Constantinescu, R. ;
Thompson, J. P. ;
Biglan, K. M. ;
Holloway, R. G. ;
Kieburtz, K. ;
Marshall, F. J. ;
Ravina, B. M. ;
Schifitto, G. ;
Siderowf, A. ;
Tanner, C. M. .
NEUROLOGY, 2007, 68 (05) :384-386
[7]
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset [J].
Gan-Or, Z. ;
Giladi, N. ;
Rozovski, U. ;
Shifrin, C. ;
Rosner, S. ;
Gurevich, T. ;
Bar-Shira, A. ;
Orr-Urtreger, A. .
NEUROLOGY, 2008, 70 (24) :2277-2283
[8]
Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan [J].
Goetz, Christopher G. ;
Fahn, Stanley ;
Martinez-Martin, Pablo ;
Poewe, Werner ;
Sampaio, Cristina ;
Stebbins, Glenn T. ;
Stern, Matthew B. ;
Tilley, Barbara C. ;
Dodel, Richard ;
Dubois, Bruno ;
Holloway, Robert ;
Jankovic, Joseph ;
Kulisevsky, Jaime ;
Lang, Anthony E. ;
Lees, Andrew ;
Leurgans, Sue ;
LeWitt, Peter A. ;
Nyenhuis, David ;
Olanow, C. Warren ;
Rascol, Olivier ;
Schrag, Anette ;
Teresi, Jeanne A. ;
van Hilten, Jacobus J. ;
LaPelle, Nancy .
MOVEMENT DISORDERS, 2007, 22 (01) :41-47
[9]
Parkinsonism among Gaucher disease carriers [J].
Goker-Alpan, O ;
Schiffmann, R ;
LaMarca, ME ;
Nussbaum, RL ;
McInerney-Leo, A ;
Sidransky, E .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (12) :937-940
[10]
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations [J].
Goker-Alpan, Ozlem ;
Lopez, Grisel ;
Vithayathil, Joseph ;
Davis, Joie ;
Hallett, Mark ;
Sidransky, Ellen .
ARCHIVES OF NEUROLOGY, 2008, 65 (10) :1353-1357